RecruitingSmoking Cessation
Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to refine and pilot an intervention using the Nicotine Metabolite Ratio (NMR) to inform the selection of pharmacologic treatment to increase smoking abstinence among Alaska Native and American Indian people. This is a single-arm pilot trial to assess and improve acceptability and feasibility.
Sponsor: Southcentral Foundation
You may qualify if…
- ✓ (Patients)
- ✓ Alaska Native or American Indian person by self-report
- ✓ eligible for or already receiving services at Southcentral Foundation (SCF)
- ✓ age 18 years or older
- ✓ daily smoking in the past 30-days
- ✓ if other nicotine or tobacco products are used, cigarettes are main product used
- ✓ planning to schedule an appointment with the Quit Tobacco Program to seek smoking cessation treatment in the next 30 days
- ✓ willing to make a quit attempt within 30 days of enrollment in the Quit Tobacco Program
You may not qualify if…
- ✕ (Patients)
- ✕ Participated in the prior study phase
- ✕ participated in a cessation program during the past 3 months
- ✕ their provider has not approved varenicline in their referral to the Quit Tobacco Program
- ✕ has history of serious hypersensitivity or skin reactions to varenicline
- ✕ has bleeding disorder or is currently receiving cancer treatment
- ✕ questionable capacity or impaired decision-making capacity
Where it's recruiting
Alaska
Anchorage
Source: ClinicalTrials.gov · NCT06556238 · last updated 2026-04-24